Skip to main content
Premium Trial:

Request an Annual Quote

Micronics Licenses Biosearch Technologies' Chemistries

NEW YORK (GenomeWeb News) – Point-of-care diagnostic developer Micronics and Biosearch Technologies have struck a license agreement related to nucleic acid assay chemistries, Micronics said today.

Micronics has licensed the right to make, use, and sell products using Biosearch's fluorophores and quencher dyes.

The company is developing a line of point-of-care molecular diagnostic tests for infectious disease diagnosis and forensic testing. Based on Micronics' microfluidic tools that reduce the volume of a sample taken from a patient and the reagents required, the tests will target E. coli, malaria, and respiratory diseases.

Micronics will use Biosearch's Black Hole Quencher, CAL Fluor, and Quasar dye technologies, along with molecular beacons probe technology that Micronics licensed from PHRI Properties.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.